The Hematologic Malignancies Market is projected to grow from USD 72,200.85 million in 2024 to USD 128,481.41 million by 2032, registering a CAGR of 7.47% during 2024--2032. Growth is underpinned by ...

Droplet Biosciences uses lymph fluid and NVIDIA Parabricks to detect residual cancer faster and cut analysis time and costs.

The Companion Diagnostics Market has emerged as a critical pillar of modern precision medicine, enabling healthcare providers to match patients with therapies that are most likely to deliver effective ...

Experts call for early diagnosis, prophylaxis in hemophilia, improved MS policy frameworks, genomic testing access and ...

In Partnership with ATC Genomics, the Company Presented One of Asia's Largest Real-World Datasets (n=12,281) for AI-Powered ...

Pillar Biosciences today announced the launch of the oncoReveal® Rapid AML Panel, a focused research-use-only (RUO) DNA next-generation sequencing (NGS) panel designed to help laboratories generate ...

Global Liquid Biopsy Market OverviewThe global liquid biopsy market is anticipated to register a strong compound annual growth rate of around 17% through 2031, driven by the increasing global burden ...

Thanks to advances in imaging and diagnostic technologies, clinicians can now detect many genetic disorders in the womb, ...

Antalya [Turkey], March 4: Gene Solutions announced its strategic entry into the Turkish market at the 2nd International Hereditary Cancers Congress (IHCC), held 05-08 February 2026 in Antalya.

In Partnership with ATC Genomics, the Company Presented One of Asia's Largest Real-World Datasets (n=12,281) for AI-Powered Multi-Cancer Early Detection (MCED) and Showcased its Clinically Validated ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...